645 filings
Page 5 of 33
8-K
je1wyyok bzcdr6bq1v
1 Oct 21
Departure of Directors or Certain Officers
4:06pm
8-K
yekpslo 3c
27 Sep 21
Ziopharm Oncology Announces Strategic Reduction in Workforce and Extension in Cash Runway
4:05pm
8-K
drig7m6had l4um
30 Aug 21
Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions
5:25pm
8-K
x0pq9
12 Aug 21
Entry into a Material Definitive Agreement
4:57pm
NT 10-Q
1u2 yr3m5xtby
9 Aug 21
Notice of late quarterly filing
5:07pm
8-K
izvhqi gwy48t1job1
9 Aug 21
Ziopharm Oncology Provides Second Quarter 2021 Corporate Updates
5:04pm
8-K
hxy2l4gx34qs2
21 May 21
Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting
4:01pm
8-K
54pbrv5x
13 May 21
Departure of Directors or Certain Officers
4:31pm
8-K
ugoabzmz1x8hdd
6 May 21
Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:17pm
8-K
i2vb17exe0bp5tkd
9 Apr 21
Departure of Directors or Certain Officers
8:45am
DEFA14A
fu1h8ct
7 Apr 21
Additional proxy soliciting materials
8:49am
8-K
dgvtf t17
25 Mar 21
Departure of Directors or Certain Officers
12:00am
SEC STAFF
ml2rzk64xifh8
11 Mar 21
SEC staff action: Order
12:00am
8-K
s09mzc9uy4aa8i7s6m
2 Mar 21
Departure of Directors or Certain Officers
4:01pm
8-K
73d14my5x3i2wtoix
25 Feb 21
Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm